ARTICLE | Clinical News
Doripenem regulatory update
December 18, 2006 8:00 AM UTC
JNJ submitted an NDA for its doripenem to treat complicated intra-abdominal and complicated urinary tract infections. JNJ gained the broad spectrum carbapenem antibiotic through its acquisition of inf...